microRNA Predict Acute Lymphoblastic Leukemia Risk for Relapse at Diagnosis

Curewize is proud to announce the publication of our researchers work on the ProALL technology. The pubication miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer. Avigad et al., 2016;55:328-339 shows the discovery, design and validation of the ProALL microRNA biomarker in two seperate treatment cohorts.